Shanghai Fosun Pharma gets conditional NMPA approval for GR1803
Shanghai Fosun Pharma received marketing registration approval with conditions for GR1803 from the NMPA.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.